tmccortt_400x550

Thomas McCourt

President’s Award

Crystal Awards Honoree

I am honored and humbled to accept the 2022 ASGE President's Award. It has been a pleasure working with Doug Rex and the ASGE for so many years and I am proud to be part of the ongoing efforts to advance innovation and care in GI endoscopy. My collaboration with the ASGE spans over 30 years and I have had the great fortune to be involved in so many meaningful programs including the ASGE Young Investigator and Practice Management Conferences, the Clinical Outcomes Research Initiative and the ASGE Board of Trustees.  I truly believe that when industry and professional organizations work collaboratively, we can provide even more value to the GI community.

Tom McCourt joined Ironwood in 2009. He has served as chief executive officer and member of the board of directors since June 2021. Prior to that, Tom served as president and interim chief executive officer, senior vice president of marketing and sales and chief commercial officer. Prior to joining Ironwood, he led the U.S. brand team for denosumab at Amgen Inc. Previously, Tom was with Novartis AG, where he directed the launch and growth of ZELNORM™ for the treatment of patients with IBS-C and CIC and held a number of senior commercial roles, including vice president of strategic marketing and operations. He was also part of the founding team at Astra Merck Inc., leading the development of the medical affairs and science liaison group and then serving as brand manager for PRILOSEC® and NEXIUM®. Tom serves on the board of directors, including on the audit and compensation committees, of Acceleron Pharma Inc. and has a degree in pharmacy from the University of Wisconsin.